Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters










Publication year range
1.
Cells ; 10(10)2021 09 23.
Article in English | MEDLINE | ID: mdl-34685494

ABSTRACT

Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy of CD4+ T-cells associated with HTLV-1 infection. In this study, we used the model of immunodeficient NSG mice reconstituted with a functional human immune system (HIS) to investigate early events in HTLV-1 pathogenesis. Upon infection, human T-cells rapidly increased in the blood and lymphoid tissues, particularly CD4+CD25+ T-cells. Proliferation of CD4+ T-cells in the spleen and mesenteric lymph nodes (MLN) correlated with HTLV-1 proviral load and CD25 expression. In addition, splenomegaly, a common feature of ATLL in humans, was also observed. CD4+ and CD8+ T-cells predominantly displayed an effector memory phenotype (CD45RA-CCR7-) and expressed CXCR3 and CCR5 chemokine receptors, suggesting the polarization into a Th1 phenotype. Activated CD8+ T-cells expressed granzyme B and perforin; however, the interferon-γ response by these cells was limited, possibly due to elevated PD-1 expression and increased frequency of CD4+FoxP3+ regulatory T-cells in MLN. Thus, HTLV-1-infected HIS-NSG mice reproduced several characteristics of infection in humans, and it may be helpful to investigate ATLL-related events and to perform preclinical studies. Moreover, aspects of chronic infection were already present at early stages in this experimental model. Collectively, we suggest that HTLV-1 infection modulates host immune responses to favor viral persistence.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Cell Differentiation/immunology , HTLV-I Infections/virology , Human T-lymphotropic virus 1/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/virology , HTLV-I Infections/immunology , Human T-lymphotropic virus 1/metabolism , Humans , Leukemia-Lymphoma, Adult T-Cell/immunology , Leukemia-Lymphoma, Adult T-Cell/pathology , Leukemia-Lymphoma, Adult T-Cell/virology , Leukocyte Common Antigens/metabolism , Mice , Persistent Infection/immunology , Persistent Infection/virology
2.
MAbs ; 12(1): 1845908, 2020.
Article in English | MEDLINE | ID: mdl-33218286

ABSTRACT

Recent studies have shown the potential of broadly neutralizing antibodies (bnAbs) for HIV-1 treatment. One of the candidate antibodies moving into clinical trials is the bnAb PGDM1400. Here, we studied the therapeutic potency and escape pathways of bnAb PGDM1400 during monovalent therapy in human immune system (HIS) mice using the BG505, REJO, MJ4 and AMC008 virus isolates. PGDM1400 administered during chronic infection caused a modest decrease in viral load in the first week of administration in 7 out of 10 animals, which correlated with the in vitro neutralization sensitivity of the viruses to PGDM1400. As expected for monotherapy, viral loads rebounded after about a week and different viral escape pathways were observed, involving the deletion of glycans in the envelope glycoprotein at positions 130 or 160. (Pre)clinical trials should reveal whether PGDM1400 is a useful component of an antibody combination treatment or as part of a tri-specific antibody.


Subject(s)
Broadly Neutralizing Antibodies/immunology , HIV Antibodies/immunology , HIV Infections/immunology , HIV-1/immunology , Animals , Humans , Mice
3.
AIDS Res Hum Retroviruses ; 34(9): 790-793, 2018 09.
Article in English | MEDLINE | ID: mdl-30003812

ABSTRACT

Broadly neutralizing antibodies (bNAbs) such as PGDM1400 show promise as prophylactic and therapeutic agents against HIV-1. Human immune system mice were passively immunized with different doses of PGDM1400 and challenged 24 h later with a high dose of HIV-1JRCSF. We found that PGDM1400 provided protection against HIV-1 challenge in a concentration dependent manner and that the protective concentration in blood was ∼75-fold higher than the in vitro 50% inhibitory concentration. The results demonstrate that PGDM1400 might be a promising component of strategies to prevent HIV-1 infection and provide support for the pursuit of vaccines that induce PGDM1400-like bNAbs.


Subject(s)
Antibodies, Neutralizing/immunology , HIV Antibodies/immunology , HIV Infections/immunology , HIV-1/immunology , Animals , Antibodies, Monoclonal/immunology , HIV Seropositivity/immunology , Humans , Inhibitory Concentration 50 , Mice , Neutralization Tests/methods , Simian Acquired Immunodeficiency Syndrome/immunology
4.
J Clin Invest ; 128(7): 2802-2818, 2018 07 02.
Article in English | MEDLINE | ID: mdl-29781813

ABSTRACT

NOTCH1 is a prevalent signaling pathway in T cell acute lymphoblastic leukemia (T-ALL), but crucial NOTCH1 downstream signals and target genes contributing to T-ALL pathogenesis cannot be retrospectively analyzed in patients and thus remain ill defined. This information is clinically relevant, as initiating lesions that lead to cell transformation and leukemia-initiating cell (LIC) activity are promising therapeutic targets against the major hurdle of T-ALL relapse. Here, we describe the generation in vivo of a human T cell leukemia that recapitulates T-ALL in patients, which arises de novo in immunodeficient mice reconstituted with human hematopoietic progenitors ectopically expressing active NOTCH1. This T-ALL model allowed us to identify CD44 as a direct NOTCH1 transcriptional target and to recognize CD44 overexpression as an early hallmark of preleukemic cells that engraft the BM and finally develop a clonal transplantable T-ALL that infiltrates lymphoid organs and brain. Notably, CD44 is shown to support crucial BM niche interactions necessary for LIC activity of human T-ALL xenografts and disease progression, highlighting the importance of the NOTCH1/CD44 axis in T-ALL pathogenesis. The observed therapeutic benefit of anti-CD44 antibody administration in xenotransplanted mice holds great promise for therapeutic purposes against T-ALL relapse.


Subject(s)
Hyaluronan Receptors/metabolism , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/etiology , Receptor, Notch1/metabolism , Animals , Cell Line, Tumor , Cell Transformation, Neoplastic , Hematopoietic Stem Cell Transplantation , Heterografts , Humans , Mice , Mice, Inbred NOD , Mice, Knockout , Mice, SCID , Mutation , Neoplasm Transplantation , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/immunology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Receptor, Notch1/genetics , Signal Transduction
5.
Stem Cells Dev ; 25(12): 934-47, 2016 06 15.
Article in English | MEDLINE | ID: mdl-27154244

ABSTRACT

Mesenchymal stromal cells (MSCs) are applied as novel therapeutics for their regenerative and immune-suppressive capacities. Clinical applications, however, require extensive expansion of MSCs. Fetal bone marrow-derived MSCs (FBMSCs) proliferate faster than adult bone marrow-derived MSC (ABMSCs). To optimize expansion and function of MSC in general, we explored the differences between ABMSC and FBMSC. Gene expression profiling implicated differential expression of genes encoding proteins in the Wnt signaling pathway, including excreted inhibitors of Wnt signaling, particularly by ABMSC. Both MSC types had a similar basal level of canonical Wnt signaling. Abrogation of autocrine Wnt production by inhibitor of Wnt production-2 (IWP2) reduced canonical Wnt signaling and cell proliferation of FBMSCs, but hardly affected ABMSC. Addition of exogenous Wnt3a, however, induced expression of the target genes lymphocyte enhancer-binding factor (LEF) and T-cell factor (TCF) faster and at lower Wnt3a levels in ABMSC compared to FBMSC. Medium replacement experiments indicated that ABMSC produce an inhibitor of Wnt signaling that is effective on ABMSC itself but not on FBMSC, whereas FBMSC excrete (Wnt) factors that stimulate proliferation of ABMSC. In contrast, FBMSC were not able to support hematopoiesis, whereas ABMSC displayed hematopoietic support sensitive to IWP2, the inhibitor of Wnt factor excretion. In conclusion, ABMSC and FBMSC differ in their Wnt signature. While FBMSC produced factors, including Wnt signals, that enhanced MSC proliferation, ABMSC produced Wnt factors in a setting that enhanced hematopoietic support. Thus, further unraveling the molecular basis of this phenomenon may lead to improvement of clinical expansion protocols of ABMSCs.


Subject(s)
Bone Marrow Cells/cytology , Fetus/cytology , Mesenchymal Stem Cells/metabolism , Wnt Signaling Pathway , Adult , Bone Marrow Cells/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Culture Media, Conditioned/pharmacology , Gene Expression Profiling , Gene Expression Regulation/drug effects , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/drug effects , Humans , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/drug effects , Oligonucleotide Array Sequence Analysis , Solubility , Wnt Proteins/metabolism , Wnt Signaling Pathway/drug effects
6.
PLoS One ; 10(3): e0119820, 2015.
Article in English | MEDLINE | ID: mdl-25782010

ABSTRACT

Hepatic infections by hepatitis B virus (HBV), hepatitis C virus (HCV) and Plasmodium parasites leading to acute or chronic diseases constitute a global health challenge. The species tropism of these hepatotropic pathogens is restricted to chimpanzees and humans, thus model systems to study their pathological mechanisms are severely limited. Although these pathogens infect hepatocytes, disease pathology is intimately related to the degree and quality of the immune response. As a first step to decipher the immune response to infected hepatocytes, we developed an animal model harboring both a human immune system (HIS) and human hepatocytes (HUHEP) in BALB/c Rag2-/- IL-2Rγc-/- NOD.sirpa uPAtg/tg mice. The extent and kinetics of human hepatocyte engraftment were similar between HUHEP and HIS-HUHEP mice. Transplanted human hepatocytes were polarized and mature in vivo, resulting in 20-50% liver chimerism in these models. Human myeloid and lymphoid cell lineages developed at similar frequencies in HIS and HIS-HUHEP mice, and splenic and hepatic compartments were humanized with mature B cells, NK cells and naïve T cells, as well as monocytes and dendritic cells. Taken together, these results demonstrate that HIS-HUHEP mice can be stably (> 5 months) and robustly engrafted with a humanized immune system and chimeric human liver. This novel HIS-HUHEP model provides a platform to investigate human immune responses against hepatotropic pathogens and to test novel drug strategies or vaccine candidates.


Subject(s)
Disease Models, Animal , Hepatocytes/immunology , Immune System/physiology , Liver Diseases/immunology , Mice , Animals , B-Lymphocytes/immunology , B-Lymphocytes/physiology , B-Lymphocytes/transplantation , Cell Lineage , Cells, Cultured , Chimerism , Hepatocytes/parasitology , Hepatocytes/virology , Humans , Immune System/cytology , Killer Cells, Natural/immunology , Killer Cells, Natural/physiology , Killer Cells, Natural/transplantation , Kinetics , Liver Diseases/parasitology , Liver Diseases/virology , Mice, Inbred BALB C , Mice, Inbred NOD , T-Lymphocytes/immunology , T-Lymphocytes/physiology , T-Lymphocytes/transplantation
7.
Sensors (Basel) ; 14(8): 14806-38, 2014 Aug 13.
Article in English | MEDLINE | ID: mdl-25123465

ABSTRACT

An emerging demand for the precise manipulation of cells and particles for applications in cell biology and analytical chemistry has driven rapid development of ultrasonic manipulation technology. Compared to the other manipulation technologies, such as magnetic tweezing, dielectrophoresis and optical tweezing, ultrasonic manipulation has shown potential in a variety of applications, with its advantages of versatile, inexpensive and easy integration into microfluidic systems, maintenance of cell viability, and generation of sufficient forces to handle particles, cells and their agglomerates. This article briefly reviews current practice and reports our development of various ultrasonic standing wave manipulation devices, including simple devices integrated with high frequency (>20 MHz) ultrasonic transducers for the investigation of biological cells and complex ultrasonic transducer array systems to explore the feasibility of electronically controlled 2-D and 3-D manipulation. Piezoelectric and passive materials, fabrication techniques, characterization methods and possible applications are discussed. The behavior and performance of the devices have been investigated and predicted with computer simulations, and verified experimentally. Issues met during development are highlighted and discussed. To assist long term practical adoption, approaches to low-cost, wafer level batch-production and commercialization potential are also addressed.


Subject(s)
Acoustics/instrumentation , Microfluidic Analytical Techniques/instrumentation , Cell Survival/physiology , Computer Simulation , Equipment Design/instrumentation , Microfluidics/instrumentation , Transducers , Ultrasonics/instrumentation
8.
Mol Ther Nucleic Acids ; 2: e120, 2013 Sep 03.
Article in English | MEDLINE | ID: mdl-24002730

ABSTRACT

Highly active antiretroviral therapy (HAART) has significantly improved the quality of life and the life expectancy of HIV-infected individuals. Still, drug-induced side effects and emergence of drug-resistant viral variants remain important issues that justify the exploration of alternative therapeutic options. One strategy consists of a gene therapy based on RNA interference to induce the sequence-specific degradation of the HIV-1 RNA genome. We have selected four potent short hairpin RNA (shRNA) candidates targeting the viral capside, integrase, protease and tat/rev open-reading frames and screened the safety of them during human hematopoietic cell development, both in vitro and in vivo. Although the four shRNA candidates appeared to be safe in vitro, one shRNA candidate impaired the in vivo development of the human immune system in Balb/c Rag2(-/-)IL-2Rγc(-/-) (BRG) mice. The three remaining shRNA candidates were combined into one single lentiviral vector (LV), and safety of the shRNA combination during human hematopoietic cell development was confirmed. Overall, we demonstrate here the preclinical in vivo safety of a LV expressing three shRNAs against HIV-1, which is proposed for a future Phase I clinical trial.Molecular Therapy-Nucleic Acids (2013) 2, e120; doi:10.1038/mtna.2013.48; published online 3 September 2013.

9.
Nat Immunol ; 14(3): 221-9, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23334791

ABSTRACT

Innate lymphoid cells (ILCs) are effectors of innate immunity and regulators of tissue modeling. Recently identified ILC populations have a cytokine expression pattern that resembles that of the helper T cell subsets T(H)2, T(H)17 and T(H)22. Here we describe a distinct ILC subset similar to T(H)1 cells, which we call 'ILC1'. ILC1 cells expressed the transcription factor T-bet and responded to interleukin 12 (IL-12) by producing interferon-γ (IFN-γ). ILC1 cells were distinct from natural killer (NK) cells as they lacked perforin, granzyme B and the NK cell markers CD56, CD16 and CD94, and could develop from RORγt(+) ILC3 under the influence of IL-12. The frequency of the ILC1 subset was much higher in inflamed intestine of people with Crohn's disease, which indicated a role for these IFN-γ-producing ILC1 cells in the pathogenesis of gut mucosal inflammation.


Subject(s)
Crohn Disease/immunology , Interleukin-12/metabolism , Intestinal Mucosa/immunology , Lymphocyte Subsets/immunology , Lymphocytes/immunology , T-Box Domain Proteins/biosynthesis , Animals , CD56 Antigen/analysis , Cell Differentiation , Cells, Cultured , Colitis/immunology , Cytokines/immunology , Cytokines/metabolism , Granzymes/analysis , Humans , Inflammation , Interferon-gamma/biosynthesis , Intestinal Mucosa/metabolism , Intestines/immunology , Killer Cells, Natural/immunology , Lymphocyte Subsets/metabolism , Lymphocytes/metabolism , Mice , NK Cell Lectin-Like Receptor Subfamily D/analysis , Nuclear Receptor Subfamily 1, Group F, Member 3/genetics , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , Perforin/analysis , Receptors, IgG/analysis , Th1 Cells/immunology , Th1 Cells/metabolism
10.
Exp Dermatol ; 21(9): 706-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22897578

ABSTRACT

Sézary syndrome (SS) is an aggressive cutaneous T-cell lymphoma with CD4+ tumor cells localized in the skin, lymph nodes and peripheral blood. Characteristic molecular aberrancies in SS have been identified; however, paucity of functional models severely hampered the translation of these observations into pathogenic mechanisms, and subsequent validation of novel therapeutic targets. We therefore developed a mouse model for SS using intrahepatic injection of SS cells in newborn immunodeficient RAG2(-/-) γc(-/-) mice that are completely devoid of T-, B- and NK-cell activity. Injection of the SS cell line SeAx led to long-term and reproducible systemic repopulation of the mice. Injection of mice with the SS cell line HuT-78 led to the death of the mice owing to massive growth of internal tumors. Four weeks after injection of primary SS cells, human CD3+ T cells could be tracked back in the liver, peripheral blood, lymph nodes, spleen and skin of the mice, although the engraftment rate varied when using cells from different patients. In conclusion, we demonstrate that injection of SS cell lines or primary cells in newborn RAG2(-/-) γc(-/-) mice results in long-term systemic repopulation of the mice, thereby providing a novel mouse model for Sézary syndrome.


Subject(s)
DNA-Binding Proteins/genetics , Disease Models, Animal , Sezary Syndrome/pathology , Skin Neoplasms/pathology , Animals , CD4-Positive T-Lymphocytes/transplantation , Humans , Interleukin-2 Receptor alpha Subunit/metabolism , Ki-67 Antigen/metabolism , Lymph Nodes/metabolism , Mice , Mice, Knockout , Mice, SCID , Neoplasm Transplantation , Sezary Syndrome/immunology , Sezary Syndrome/metabolism , Skin Neoplasms/immunology , Skin Neoplasms/metabolism
11.
J Gen Virol ; 93(Pt 9): 2017-2027, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22647372

ABSTRACT

A novel genetic approach for the control of virus replication was used for the design of a conditionally replicating human immunodeficiency virus (HIV) variant, HIV-rtTA. HIV-rtTA gene expression and virus replication are strictly dependent on the presence of a non-toxic effector molecule, doxycycline (dox), and thus can be turned on and off at will in a graded and reversible manner. The in vivo replication capacity, pathogenicity and genetic stability of this HIV-rtTA variant were evaluated in a humanized mouse model of haematopoiesis that harbours lymphoid and myeloid components of the human immune system (HIS). Infection of dox-fed BALB Rag/γc HIS (BRG-HIS) mice with HIV-rtTA led to the establishment of a productive infection without CD4(+) T-cell depletion. The virus did not show any sign of escape from dox control for up to 10 weeks after the onset of infection. No reversion towards a functional Tat-transactivating responsive (TAR) RNA element axis was observed, confirming the genetic stability of the HIV-rtTA variant in vivo. These results demonstrate the proof of concept that HIV-rtTA replicates efficiently in vivo. HIV-rtTA is a promising tool for fundamental research to study virus-host interactions in vivo in a controlled fashion.


Subject(s)
CD4-Positive T-Lymphocytes/virology , Doxycycline/metabolism , Gene Expression Regulation, Viral , HIV Infections/immunology , HIV Infections/virology , HIV-1/physiology , Virus Replication , Animals , CD4-Positive T-Lymphocytes/immunology , Cells, Cultured , HIV-1/genetics , Humans , Lymphocyte Depletion , Mice , Mice, Inbred BALB C , Mice, Knockout
12.
Stem Cells Dev ; 21(2): 228-38, 2012 Jan 20.
Article in English | MEDLINE | ID: mdl-21480782

ABSTRACT

Detailed understanding of mesenchymal stromal cells (MSC) migration is imperative for future cellular therapies. To identify genes involved in the process of MSC migration, we generated gene expression profiles of migrating and nonmigrating fetal bone marrow MSC (FBMSC). Only 12 genes showed differential expression in migrating versus nonmigrating FBMSC. The nuclear receptors Nur77 and Nurr1 showed the highest expression in migratory MSC. Nur77 and Nurr1 are members of NR4A nuclear orphan receptor family, and we found that their expression is rapidly increased upon exposure of FBMSC to the migratory stimuli stromal-derived factor-1α (SDF-1α) and platelet-derived growth factor-BB. Lentiviral expression of Nur77 or Nurr1 resulted in enhanced migration of FBMSC toward SDF-1α compared with mock-transduced FBMSC. Analysis of the cell cycle, known to be involved in MSC migration, revealed that expression of Nur77 and Nurr1 decreases the proportion of cells in S-phase compared with control cells. Further, gain-of-function experiments showed increased hepatocyte growth factor expression and interleukin (IL)-6 and IL-8 production in MSC. Despite the altered cytokine profile, FBMSC expressing Nur77 or Nurr1 maintained the capacity to inhibit T-cell proliferation in a mixed lymphocyte reaction. Our results demonstrate that Nur77 and Nurr1 promote FBMSC migration. Modulation of Nur77 and Nurr1 activity may therefore offer perspectives to enhance the migratory potential of FBMSC which may specifically regulate the local immune response.


Subject(s)
Bone Marrow/physiology , Cell Movement/genetics , Gene Expression Regulation , Mesenchymal Stem Cells/metabolism , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Nuclear Receptor Subfamily 4, Group A, Member 2/genetics , Becaplermin , Cell Cycle/drug effects , Cell Cycle/genetics , Cell Movement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Chemokine CXCL12/pharmacology , Fetus , Gene Expression Profiling , Gene Expression Regulation/drug effects , Hepatocyte Growth Factor/genetics , Hepatocyte Growth Factor/metabolism , Humans , Interleukin-6/biosynthesis , Interleukin-8/biosynthesis , Lentivirus , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/drug effects , Nuclear Receptor Subfamily 4, Group A, Member 1/metabolism , Nuclear Receptor Subfamily 4, Group A, Member 2/metabolism , Proto-Oncogene Proteins c-sis/pharmacology , Signal Transduction/drug effects , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , Transfection
13.
Eur J Immunol ; 41(10): 2883-93, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21739431

ABSTRACT

Human Immune System (HIS) mice represent a novel biotechnology platform to dissect human haematopoiesis and immune responses. However, the limited human T-cell development that is observed in HIS mice restricts its utility for these applications. Here, we address whether reduced thymopoiesis in HIS mice reflects an autonomous defect in T-cell precursors and/or a defect in the murine thymic niche. Human thymocyte precursors seed the mouse thymus and their reciprocal interactions with murine thymic epithelial cells (TECs) led to both T-cell and TEC maturation. The human thymocyte subsets observed in HIS mice demonstrated survival, proliferative and phenotypic characteristics of their normal human counterparts, suggesting that the intrinsic developmental program of human thymocytes unfolds normally in this xenograft setting. We observed that exogenous administration of human IL-15/IL-15Rα agonistic complexes induced the survival, proliferation and absolute numbers of immature human thymocyte subsets, without any obvious effect on cell-surface phenotype or TCR Vß usage amongst the newly selected mature single-positive (SP) thymocytes. Finally, when IL-15 was administered early after stem cell transplantation, we noted accelerated thymopoiesis resulting in the more rapid appearance of peripheral naïve T cells. Our results highlight the functional capacity of murine thymic stroma cells in promoting human thymopoiesis in HIS mice but suggest that the "cross-talk" between murine thymic stroma and human haematopoietic precursors may be suboptimal. As IL-15 immunotherapy promotes early thymopoiesis, this novel approach could be used to reduce the period of T-cell immunodeficiency in the post-transplant clinical setting.


Subject(s)
Interleukin-15/pharmacology , Lymphopoiesis , Precursor Cells, T-Lymphoid/metabolism , Thymocytes/cytology , Thymus Gland/cytology , Animals , Cell Communication , Cell Differentiation , Chimera/immunology , Epithelial Cells/cytology , Epithelial Cells/metabolism , Flow Cytometry , Humans , Interleukin-15/antagonists & inhibitors , Lymphocyte Activation , Lymphopoiesis/drug effects , Mice , Mice, Inbred BALB C , Receptors, Antigen, T-Cell, alpha-beta/immunology , Receptors, Interleukin-15/antagonists & inhibitors , Stem Cell Transplantation , Thymocytes/immunology , Thymocytes/metabolism
14.
Proc Natl Acad Sci U S A ; 108(32): 13224-9, 2011 Aug 09.
Article in English | MEDLINE | ID: mdl-21788504

ABSTRACT

The homeostatic control mechanisms regulating human leukocyte numbers are poorly understood. Here, we assessed the role of phagocytes in this process using human immune system (HIS) BALB/c Rag2(-/-)IL-2Rγc(-/-) mice in which human leukocytes are generated from transplanted hematopoietic progenitor cells. Interactions between signal regulatory protein alpha (SIRPα; expressed on phagocytes) and CD47 (expressed on hematopoietic cells) negatively regulate phagocyte activity of macrophages and other phagocytic cells. We previously showed that B cells develop and survive robustly in HIS mice, whereas T and natural killer (NK) cells survive poorly. Because human CD47 does not interact with BALB/c mouse SIRPα, we introduced functional CD47/SIRPα interactions in HIS mice by transducing mouse CD47 into human progenitor cells. Here, we show that this procedure resulted in a dramatic and selective improvement of progenitor cell engraftment and human T- and NK-cell homeostasis in HIS mouse peripheral lymphoid organs. The amount of engrafted human B cells also increased but much less than that of T and NK cells, and total plasma IgM and IgG concentrations increased 68- and 35-fold, respectively. Whereas T cells exhibit an activated/memory phenotype in the absence of functional CD47/SIRPα interactions, human T cells accumulated as CD4(+) or CD8(+) single-positive, naive, resting T cells in the presence of functional CD47/SIRPα interactions. Thus, in addition to signals mediated by T cell receptor (TCR)/MHC and/or IL/IL receptor interactions, sensing of cell surface CD47 expression by phagocyte SIRPα is a critical determinant of T- and NK-cell homeostasis under steady-state conditions in vivo.


Subject(s)
Antigens, Differentiation/metabolism , CD47 Antigen/metabolism , Homeostasis , Killer Cells, Natural/metabolism , Receptors, Immunologic/metabolism , T-Lymphocytes/metabolism , Animals , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/metabolism , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/metabolism , Humans , Interleukin Receptor Common gamma Subunit/metabolism , Killer Cells, Natural/cytology , Kinetics , Lymphopoiesis , Mice , Mice, Inbred BALB C , Mice, Inbred NOD , Protein Binding , Receptors, Interleukin-2/deficiency , Receptors, Interleukin-2/metabolism , Spleen/cytology , Spleen/immunology , Survival Analysis , T-Lymphocytes/cytology , Thymus Gland/metabolism , Transplantation, Heterologous
15.
Blood ; 117(22): 5892-6, 2011 Jun 02.
Article in English | MEDLINE | ID: mdl-21502542

ABSTRACT

A girl presented during childhood with a single course of extensive chickenpox and moderate albeit recurrent pneumonia in the presence of idiopathic CD4+ T lymphocytopenia (ICL). Her clinical condition remained stable over the past 10 years without infections, any granulomatous disease, or autoimmunity. Immunophenotyping demonstrated strongly reduced naive T and B cells with intact proliferative capacity. Antibody reactivity on in vivo immunizations was normal. T-cell receptor-Vß repertoire was polyclonal with a very low content of T-cell receptor excision circles (TRECs). Kappa-deleting recombination excision circles (KRECs) were also abnormal in the B cells. Both reflect extensive in vivo proliferation. Patient-derived CD34+ hematopoietic stem cells could not repopulate RAG2(-/-)IL2Rγc(-/-) mice, indicating the lymphoid origin of the defect. We identified 2 novel missense mutations in RAG1 (p.Arg474Cys and p.Leu506Phe) resulting in reduced RAG activity. This report gives the first genetic clue for ICL and extends the clinical spectrum of RAG mutations from severe immune defects to an almost normal condition.


Subject(s)
Autoimmunity , CD4-Positive T-Lymphocytes/immunology , Granulomatous Disease, Chronic/immunology , Homeodomain Proteins/genetics , Mutation/genetics , T-Lymphocytopenia, Idiopathic CD4-Positive/genetics , T-Lymphocytopenia, Idiopathic CD4-Positive/immunology , Amino Acid Sequence , Animals , Cells, Cultured , Child, Preschool , DNA-Binding Proteins/physiology , Female , Humans , Mice , Mice, Knockout , Molecular Sequence Data , Receptors, Interleukin-2/physiology , Sequence Homology, Amino Acid
16.
Blood ; 117(23): 6162-71, 2011 Jun 09.
Article in English | MEDLINE | ID: mdl-21471524

ABSTRACT

The development and antigen-dependent differentiation of B lymphocytes are orchestrated by an array of growth factors, cytokines, and chemokines that require tight spatiotemporal regulation. Heparan sulfate proteoglycans specifically bind and regulate the bioavailability of soluble protein ligands, but their role in the immune system has remained largely unexplored. Modification of heparan sulfate by glucuronyl C5-epimerase (Glce) controls heparan sulfate-chain flexibility and thereby affects ligand binding. Here we show that Glce deficiency impairs B-cell maturation, resulting in decreased plasma cell numbers and immunoglobulin levels. We demonstrate that C5-epimerase modification of heparan sulfate is critical for binding of a proliferation inducing ligand (APRIL) and that Glce-deficient plasma cells fail to respond to APRIL-mediated survival signals. Our results identify heparan sulfate proteoglycans as novel players in B-cell maturation and differentiation and suggest that heparan sulfate conformation is crucial for recruitment of factors that control plasma cell survival.


Subject(s)
Carbohydrate Epimerases/immunology , Cell Differentiation/immunology , Heparan Sulfate Proteoglycans/immunology , Plasma Cells/immunology , Signal Transduction/immunology , Tumor Necrosis Factor Ligand Superfamily Member 13/immunology , Animals , Carbohydrate Epimerases/genetics , Cell Differentiation/genetics , Cell Survival/genetics , Cell Survival/immunology , Heparan Sulfate Proteoglycans/genetics , Heparan Sulfate Proteoglycans/metabolism , Mice , Mice, Knockout , Plasma Cells/enzymology , Signal Transduction/genetics , Tumor Necrosis Factor Ligand Superfamily Member 13/genetics , Tumor Necrosis Factor Ligand Superfamily Member 13/metabolism
17.
Proc Natl Acad Sci U S A ; 108(15): 6217-22, 2011 Apr 12.
Article in English | MEDLINE | ID: mdl-21444793

ABSTRACT

Cytokine immunotherapies targeting T lymphocytes are attractive clinical interventions against viruses and tumors. In the mouse, the homeostasis of memory α/ß CD8(+) T cells and natural killer (NK) cells is significantly improved with increased IL-15 bioavailability. In contrast, the role of "transpresented" IL-15 on human T-cell development and homeostasis in vivo is unknown. We found that both CD8 and CD4 T cells in human immune system (HIS) mice are highly sensitive to transpresented IL-15 in vivo, with both naïve (CD62L(+)CD45RA(+)) and memory phenotype (CD62L(-)CD45RO(+)) subsets being significantly increased following IL-15 "boosting." The unexpected global improvement in human T-cell homeostasis involved enhanced proliferation and survival of both naïve and memory phenotype peripheral T cells, which potentiated B-cell responses by increasing the frequency of antigen-specific responses following immunization. Transpresented IL-15 did not modify T-cell activation patterns or alter the global T-cell receptor (TCR) repertoire diversity. Our results indicate an unexpected effect of IL-15 on human T cells in vivo, in particular on CD4(+) T cells. As IL-15 promotes human peripheral T-cell homeostasis and increases the frequency of neutralizing antibody responses in HIS mice, IL-15 immunotherapy could be envisaged as a unique approach to improve vaccine responses in the clinical setting.


Subject(s)
Antibody Formation/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Interleukin-15/immunology , Animals , Cell Proliferation , Humans , Mice , Mice, Mutant Strains , Receptors, Antigen, T-Cell, alpha-beta/immunology , Receptors, Interleukin-15/antagonists & inhibitors
18.
PLoS One ; 5(10)2010 Oct 04.
Article in English | MEDLINE | ID: mdl-20957227

ABSTRACT

BACKGROUND: Passive transfer of antibodies not only provides immediate short-term protection against disease, but also can be exploited as a therapeutic tool. However, the 'humanization' of murine monoclonal antibodies (mAbs) is a time-consuming and expensive process that has the inherent drawback of potentially altering antigenic specificity and/or affinity. The immortalization of human B cells represents an alternative for obtaining human mAbs, but relies on the availability of biological samples from vaccinated individuals or convalescent patients. In this work we describe a novel approach to generate fully human mAbs by combining a humanized mouse model with a new B cell immortalization technique. METHODOLOGY/PRINCIPAL FINDINGS: After transplantation with CD34+CD38⁻ human hematopoietic progenitor cells, BALB/c Rag2⁻/⁻IL-2Rγc⁻/⁻ mice acquire a human immune system and harbor B cells with a diverse IgM repertoire. "Human Immune System" mice were then immunized with two commercial vaccine antigens, tetanus toxoid and hepatitis B surface antigen. Sorted human CD19+CD27+ B cells were retrovirally transduced with the human B cell lymphoma (BCL)-6 and BCL-XL genes, and subsequently cultured in the presence of CD40-ligand and IL-21. This procedure allows generating stable B cell receptor-positive B cells that secrete immunoglobulins. We recovered stable B cell clones that produced IgM specific for tetanus toxoid and the hepatitis B surface antigen, respectively. CONCLUSION/SIGNIFICANCE: This work provides the proof-of-concept for the usefulness of this novel method based on the immunization of humanized mice for the rapid generation of human mAbs against a wide range of antigens.


Subject(s)
Antibodies, Monoclonal/biosynthesis , B-Lymphocytes/immunology , Immune System , Immunoglobulin M/immunology , Animals , Cell Line, Transformed , Cell Separation , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Mice , Mice, Inbred BALB C
19.
Eur J Immunol ; 40(4): 955-65, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20127673

ABSTRACT

Thymic stromal lymphopoietin (TSLP) is a cytokine that binds the IL-7-receptor-alpha chain and a unique TSLP receptor (TSLPR) chain. The role of TSLP in human B-cell development has not been elucidated. We show that TSLPR transcripts are expressed most prominently in CD34(+) cells from fetal liver and BM. In general, cell surface expression of TSLPR was low, except on a subset of multilineage-commited progenitor cells. TSLP induced the tyrosine-phosphorylation of STAT5 and the proliferation of multilineage-commited progenitor cells, pro-B cells and pre-B cells. Compared with IL-7, the levels of proliferation after stimulation of the B-cell progenitors with TSLP were lower. Expression of the BCR on the cell surface of fetal cells was inversely correlated to TSLP or IL-7 responsiveness. Pre-B cells from fetal BM, but not fetal liver, were refractory to TSLP or IL-7 stimulation. When employing an in vitro B-cell differentiation culture system starting from CD34(+)CD38(-) multipotent HSC, IL-7 induced a short wave of precursor cell expansion but did not result in long-term survival of mature B cells. TSLP was capable of increasing the proportion and the absolute numbers of more mature human B cells. Overall, we provide evidence that TSLP supports human B-cell differentiation from fetal hematopoietic progenitors.


Subject(s)
B-Lymphocytes/cytology , Cytokines/physiology , Multipotent Stem Cells/cytology , Precursor Cells, B-Lymphoid/cytology , Bone Marrow/embryology , Cell Division/drug effects , Cell Lineage , Cells, Cultured/cytology , Cells, Cultured/drug effects , Coculture Techniques , Gene Expression Regulation, Developmental/drug effects , Humans , Interleukin-7/pharmacology , Liver/cytology , Liver/embryology , Lymphopoiesis/drug effects , Multipotent Stem Cells/drug effects , Phosphorylation , Precursor Cells, B-Lymphoid/drug effects , Protein Processing, Post-Translational , Protein-Tyrosine Kinases/metabolism , Receptors, Cytokine/biosynthesis , Receptors, Cytokine/genetics , Receptors, Cytokine/physiology , Receptors, Interleukin-7/biosynthesis , Receptors, Interleukin-7/genetics , Recombinant Proteins/pharmacology , STAT5 Transcription Factor/metabolism , Thymic Stromal Lymphopoietin
20.
Br J Haematol ; 148(3): 428-40, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19863541

ABSTRACT

Mesenchymal stromal cells (MSC) are potential cells for cellular therapies, in which the recruitment and migration of MSC towards injured tissue is crucial. Our data show that culture-expanded MSC from fetal lung and bone marrow, adult bone marrow and adipose tissue contained a small percentage of migrating cells in vitro, but the optimal stimulus was different. Overall, fetal lung-MSC had the highest migratory capacity. As fetal bone marrow-MSC had lower migratory potential than fetal lung-MSC, the tissue of origin may determine the migratory capacity of MSC. No additive effect in migration towards combined stimuli was observed, which suggests only one migratory MSC fraction. Interestingly, actin rearrangement and increased paxillin phosphorylation were observed in most MSC upon stromal cell-derived factor-1alpha or platelet-derived growth factor-BB stimulation, indicating that this mechanism involved in responding to migratory cues is not restricted to migratory MSC. Migratory MSC maintained differentiation and migration potential, and contained significantly less cells in S- and G2/M-phase than their non-migrating counterpart. In conclusion, our results suggest that MSC from various sources have different migratory capacities, depending on the tissue of origin. Similar to haematopoietic stem cells, cell cycle contributes to MSC migration, which offers perspectives for modulation of MSC to enhance efficacy of future cellular therapies.


Subject(s)
Fetus/cytology , Mesenchymal Stem Cells/physiology , Actins/metabolism , Adipose Tissue/cytology , Adult , Bone Marrow/embryology , Bone Marrow Cells/physiology , Cell Cycle/physiology , Cell Differentiation/physiology , Cell Movement/physiology , Cells, Cultured , Chemotaxis/physiology , Humans , Integrins/metabolism , Lung/cytology , Lung/embryology , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , Paxillin/metabolism , Phosphorylation , Stromal Cells/cytology , Stromal Cells/metabolism , Stromal Cells/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...